T1	Participants 541 723	Patients with ECG ST segment elevation who presented within 4 hours of symptom onset, had no contraindication to thrombolytic therapy, and were not in cardiogenic shock were enrolled
T2	Participants 1188 1234	A total of 106 patients were treated with PTCA
T3	Participants 413 519	122 patients with evolving MI to PTCA therapy with or without adjunctive intravenous streptokinase therapy
